Exhaled breath analysis to stratify cardiovascular risk using machine learning model: a novel frontier in preventive

Basheer Abdullah Marzoog1, Philipp Kopylov1

  • 1Institute of Personalized Cardiology of The Center 'Digital Biodesign and Personalized Healthcare' of Biomedical Science and Technology Park, Sechenov First Moscow State Medical University, 8-2 Trubetskaya street, 119991 Moscow, Russia.

PubMed

Insights

Machine learning models analyzing exhaled breath show potential for stratifying cardiovascular disease (CVD) risk. This non-invasive method identifies volatile organic compound patterns, aiding early detection of heart complications.

Area of Science:

  • Cardiology
  • Biomarkers
  • Machine Learning

Background:

  • Cardiovascular disease (CVD) remains a leading global cause of mortality, with early risk detection being a significant challenge in preventive cardiology.
  • Identifying individuals at high risk for serious heart complications is crucial for effective CVD prevention strategies.

Purpose of the Study:

  • To evaluate the efficacy of a machine learning model in stratifying cardiovascular disease (CVD) risk through the analysis of exhaled breath.
  • To explore the potential of volatile organic compounds (VOCs) in breath as biomarkers for CVD risk assessment.

Main Methods:

  • A single-center study involving 80 participants, comparing those with and without stress-induced myocardial perfusion defects.
  • Breath samples were collected using PTR-TOF-MS-1000, alongside blood samples and stress computed tomography myocardial perfusion imaging.
  • Machine learning models were developed using Python in Google Colab, with statistical analyses performed using Statistica and IBM SPSS.

Main Results:

  • The gradient-boosting machine learning model achieved an AUC of 0.77 for differentiating low CVD risk.
  • The model showed moderate performance in stratifying moderate (AUC 0.55) and high (AUC 0.66) CVD risk.
  • Initial findings indicate identifiable concentration patterns of specific VOCs in exhaled breath correlate with CVD risk strata.

Conclusions:

  • Exhaled breath analysis, particularly using gradient boosting machine learning, offers preliminary evidence for stratifying cardiovascular risk.
  • Further research is needed to address challenges in model performance and class imbalance for clinical application.
  • Volatile organic compound (VOC) patterns in breath may serve as a novel, non-invasive approach for cardiovascular risk assessment.